Breakthrough in understanding the cause of a rare and life-threatening condition related to sleep apnea

byBen-Gurion University of the NegevGraphical abstract. Credit:The EMBO Journal(2024). DOI: 10.1038/s44318-023-00018-9Ben-Gurion University (BGU) of the Negev's Prof. Gad Vatine

Updated on: April 23,2024

Breakthrough in understanding the cause of a rare and life-threatening condition related to sleep apnea

byBen-Gurion University of the NegevGraphical abstract. Credit:The EMBO Journal(2024). DOI: 10.1038/s44318-023-00018-9Ben-Gurion University (BGU) of the Negev's Prof. Gad Vatine

Updated on:April 23,2024

Study uncovers new insights into alternative splicing and disease associations

by Tokyo Medical and Dental UniversityStudy design to create a database of transcripts, called TRAILS (TRAnscriptomic resource of Immune cells using Long-read Sequencing), from different human im

Updated on: June 15,2024

Study uncovers new insights into alternative splicing and disease associations

by Tokyo Medical and Dental UniversityStudy design to create a database of transcripts, called TRAILS (TRAnscriptomic resource of Immune cells using Long-read Sequencing), from different human im

Updated on:June 15,2024

Bench-to-bedside drug design could lead to new Alzheimer's disease treatments

by University of GlasgowCredit: CC0 Public DomainAn international team of scientists and pharmaceutical collaborators has made a breakthrough "bench to bedside" discovery, ten years in

Updated on: May 13,2024

Bench-to-bedside drug design could lead to new Alzheimer's disease treatments

by University of GlasgowCredit: CC0 Public DomainAn international team of scientists and pharmaceutical collaborators has made a breakthrough "bench to bedside" discovery, ten years in

Updated on:May 13,2024

Beyond neurons: How cells called astrocytes contribute to brain disorders

by Salk InstituteSalk researchers studied the molecules produced by astrocytes, like those pictured, to understand how the cells play a role in neurodevelopmental disorders. Credit: Salk Institut

Updated on: February 03,2024

Beyond neurons: How cells called astrocytes contribute to brain disorders

by Salk InstituteSalk researchers studied the molecules produced by astrocytes, like those pictured, to understand how the cells play a role in neurodevelopmental disorders. Credit: Salk Institut

Updated on:February 03,2024

Exploring neurons' molecular highways: How a key protein regulates neuronal health

byOkinawa Institute of Science and TechnologyDynein is composed of two heavy chains (blue), two intermediate chains (yellow), four light intermediate chains (green) and several light chains, inc

Updated on: January 12,2024

Exploring neurons' molecular highways: How a key protein regulates neuronal health

byOkinawa Institute of Science and TechnologyDynein is composed of two heavy chains (blue), two intermediate chains (yellow), four light intermediate chains (green) and several light chains, inc

Updated on:January 12,2024

Brain changes may fuel 'long COVID' anxiety, confusion

Credit: Pixabay/CC0 Public DomainHere's more evidence of the toll that COVID-19 takes on the human brain: A new study finds biomarkers of neuron damage and brain inflammation in the blood are asso

Updated on: February 18,2024

Brain changes may fuel 'long COVID' anxiety, confusion

Credit: Pixabay/CC0 Public DomainHere's more evidence of the toll that COVID-19 takes on the human brain: A new study finds biomarkers of neuron damage and brain inflammation in the blood are asso

Updated on:February 18,2024

Constipation may be a marker for dementia risk

by Amy NortonChronic constipation may not only be an indicator of gut health, but a potential warning sign of thinking declines, a preliminary study suggests.Researchers found that among more than 110

Updated on: April 29,2024

Constipation may be a marker for dementia risk

by Amy NortonChronic constipation may not only be an indicator of gut health, but a potential warning sign of thinking declines, a preliminary study suggests.Researchers found that among more than 110

Updated on:April 29,2024

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Updated on: April 02,2024

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Updated on:April 02,2024

Older adults with mild cognitive impairment may struggle with everyday decision-making

by Keck School of Medicine of USCCredit: CC0 Public DomainMild cognitive impairment (MCI) is a form of cognitive ability loss that can precede Alzheimer's disease or other types of dementia.

Updated on: June 11,2024

Older adults with mild cognitive impairment may struggle with everyday decision-making

by Keck School of Medicine of USCCredit: CC0 Public DomainMild cognitive impairment (MCI) is a form of cognitive ability loss that can precede Alzheimer's disease or other types of dementia.

Updated on:June 11,2024

Blood-based biomarkers for Alzheimer's disease: Study in China

by Science China PressA total of 817 participants were recruited to evaluate potential alterations in blood-based biomarkers for AD among different clinical groups, including AD dementia, non-AD

Updated on: April 08,2024

Blood-based biomarkers for Alzheimer's disease: Study in China

by Science China PressA total of 817 participants were recruited to evaluate potential alterations in blood-based biomarkers for AD among different clinical groups, including AD dementia, non-AD

Updated on:April 08,2024

Blood-based biomarkers for Alzheimer's disease could greatly simplify diagnosis and reduce costs

by Hôpitaux Universitaires de GenèveProportion of traditional exams that could be saved by using plasma biomarkers with 95%-sensitivity or 95%-specificity cut-offs. Values indicate the proportion of s

Updated on: June 18,2024

Blood-based biomarkers for Alzheimer's disease could greatly simplify diagnosis and reduce costs

by Hôpitaux Universitaires de GenèveProportion of traditional exams that could be saved by using plasma biomarkers with 95%-sensitivity or 95%-specificity cut-offs. Values indicate the proportion of s

Updated on:June 18,2024

How the brain develops: A new way to shed light on cognition

by University of MontrealThe full network architecture comprises sensorimotor, cognitive, conscious, and metacognitive levels. This is a schematic representation of the full network and its compo

Updated on: February 21,2024

How the brain develops: A new way to shed light on cognition

by University of MontrealThe full network architecture comprises sensorimotor, cognitive, conscious, and metacognitive levels. This is a schematic representation of the full network and its compo

Updated on:February 21,2024